Moreover, although several studies have demonstrated that the total magnitude of CD8+ and CD4+ T cell response in people vaccinated with existing S protein–based vaccines is on par with or even surpasses that of patients who have recovered from infection (9–11, 13), it remains unclear whether the spectrum of recognized epitopes is the same in both groups. This evidence concerns the gene PROS1 and infection.